Compare ECVT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECVT | OPK |
|---|---|---|
| Founded | 1935 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | 1995 |
| Metric | ECVT | OPK |
|---|---|---|
| Price | $9.69 | $1.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $11.60 | $2.28 |
| AVG Volume (30 Days) | 1.7M | ★ 3.2M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $779,147,000.00 | $642,067,000.00 |
| Revenue This Year | $8.10 | N/A |
| Revenue Next Year | $1.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.22 | N/A |
| 52 Week Low | $5.24 | $1.11 |
| 52 Week High | $9.79 | $2.04 |
| Indicator | ECVT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 66.28 | 45.29 |
| Support Level | $9.12 | $1.29 |
| Resistance Level | $9.37 | $1.37 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 92.71 | 28.76 |
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.